These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35355557)

  • 21. Tall cell variant papillary thyroid carcinoma impacts disease-free survival at the 10 % cut-point on multivariate analysis.
    Samankan S; Militello L; Seo G; Everest S; O'Malley Q; Spaulding SL; Xing M; Matloob A; Beute J; Chai R; Doyle S; Urken ML; Brandwein-Weber M
    Pathol Res Pract; 2022 Aug; 236():154012. PubMed ID: 35834884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors for papillary thyroid cancer persistence and recurrence: a retrospective analysis with a 10-year follow-up cohort study.
    de Castro TP; Waissmann W; Simões TC; de Mello RC; Carvalho DP
    Clin Endocrinol (Oxf); 2016 Sep; 85(3):466-74. PubMed ID: 26834009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical features and prognostic factors for survival in patients with poorly differentiated thyroid carcinoma and comparison to the patients with the aggressive variants of papillary thyroid carcinoma.
    Jung TS; Kim TY; Kim KW; Oh YL; Park DJ; Cho BY; Shong YK; Kim WB; Park YJ; Jung JH; Chung JH
    Endocr J; 2007 Apr; 54(2):265-74. PubMed ID: 17379963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioactive iodine ablation may not decrease the risk of recurrence in intermediate-risk papillary thyroid carcinoma.
    Kim SK; Woo JW; Lee JH; Park I; Choe JH; Kim JH; Kim JS
    Endocr Relat Cancer; 2016 May; 23(5):367-76. PubMed ID: 26917553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
    Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
    J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multivariate analysis of the relationship between male sex, disease-specific survival, and features of tumor aggressiveness in thyroid cancer of follicular cell origin.
    Nilubol N; Zhang L; Kebebew E
    Thyroid; 2013 Jun; 23(6):695-702. PubMed ID: 23194434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of Body Mass Index on the Clinicopathologic Features of Papillary Thyroid Carcinoma.
    Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
    Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):625-632. PubMed ID: 30841713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of incomplete response to therapy among Filipino patients with papillary thyroid cancer in a tertiary hospital.
    Mendoza ES; Lopez AA; Valdez VA; Cunanan EC; Matawaran BJ; Kho SA; Sero-Gomez MH
    J Endocrinol Invest; 2016 Jan; 39(1):55-62. PubMed ID: 26036600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of recurrence after total thyroidectomy plus neck dissection and radioactive iodine ablation for high-risk papillary thyroid carcinoma.
    Kim Y; Roh JL; Song D; Cho KJ; Choi SH; Nam SY; Kim SY
    J Surg Oncol; 2020 Oct; 122(5):906-913. PubMed ID: 32588461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GADD45B Transcript Is a Prognostic Marker in Papillary Thyroid Carcinoma Patients Treated With Total Thyroidectomy and Radioiodine Therapy.
    Barros-Filho MC; de Mello JBH; Marchi FA; Pinto CAL; da Silva IC; Damasceno PKF; Soares MBP; Kowalski LP; Rogatto SR
    Front Endocrinol (Lausanne); 2020; 11():269. PubMed ID: 32425887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical implications of microscopic extrathyroidal extension in patients with papillary thyroid carcinoma.
    Park JS; Chang JW; Liu L; Jung SN; Koo BS
    Oral Oncol; 2017 Sep; 72():183-187. PubMed ID: 28222967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TERT Promoter Mutations and Tumor Persistence/Recurrence in Papillary Thyroid Cancer.
    Myung JK; Kwak BK; Lim JA; Lee MC; Kim MJ
    Cancer Res Treat; 2016 Jul; 48(3):942-7. PubMed ID: 26727717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of Hashimoto Thyroiditis in Adults With Papillary Thyroid Cancer and Its Association With Cancer Recurrence and Outcomes.
    Xu S; Huang H; Qian J; Liu Y; Huang Y; Wang X; Liu S; Xu Z; Liu J
    JAMA Netw Open; 2021 Jul; 4(7):e2118526. PubMed ID: 34313737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in the Recurrence and Survival of Patients with Symptomatic and Asymptomatic Papillary Thyroid Carcinoma: An Observational Study of 11,265 Person-Years of Follow-Up.
    Kim SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Thyroid; 2016 Oct; 26(10):1472-1479. PubMed ID: 27457917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphovascular invasion is associated with survival for papillary thyroid cancer.
    Pontius LN; Youngwirth LM; Thomas SM; Scheri RP; Roman SA; Sosa JA
    Endocr Relat Cancer; 2016 Jul; 23(7):555-62. PubMed ID: 27317633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor keratin 15 expression links with less extent of invasion and better prognosis in papillary thyroid cancer patients receiving tumor resection.
    Yang X; Liu Z; Wang X; Han Z; Zhang C; Guo L
    Ir J Med Sci; 2024 Feb; 193(1):9-15. PubMed ID: 37243844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The incidence of papillary thyroid carcinoma and outcomes in operative patients according to their body mass indices.
    Trésallet C; Seman M; Tissier F; Buffet C; Lupinacci RM; Vuarnesson H; Leenhardt L; Menegaux F
    Surgery; 2014 Nov; 156(5):1145-52. PubMed ID: 24878452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Papillary and follicular variant of papillary carcinoma of the thyroid: Initial presentation and response to therapy.
    Burningham AR; Krishnan J; Davidson BJ; Ringel MD; Burman KD
    Otolaryngol Head Neck Surg; 2005 Jun; 132(6):840-4. PubMed ID: 15944551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coexistence of papillary thyroid carcinoma in secondary hyperparathyroidism.
    Ma J; Mao Z; Yao Y; Lu Y; Wang H; Yang Y; Yang J; Wang W; Teng L
    BMC Surg; 2021 Sep; 21(1):335. PubMed ID: 34488715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.